logo
No More Pills, No More Struggles: Korean Innovation Transforms How Kids Approach Growth Support

No More Pills, No More Struggles: Korean Innovation Transforms How Kids Approach Growth Support

HAUTUKI GROWTH SUPPORT PATCH
Korean patch Hautuki ends supplement battles. Kids manage growth support independently through bedtime application. Unlike oral supplements 60% resist, transdermal system delivers nutrients through skin over 8-10 hours. Emma Chen, 9, went from hiding at vitamin time to proudly applying patches. 'Now it's drama-free,' says Hong Kong mother.
HONG KONG - Every evening at 8 PM, 9-year-old Emma Chen used to hide in her bedroom, dreading the nightly battle with her mother over growth vitamins. The familiar scene played out in households across Asia: tears, negotiations, and ultimately, a frustrated parent watching their child reluctantly swallow yet another pill.
Today, Emma looks forward to bedtime. She proudly applies a small patch near her arm – a routine she now manages entirely on her own. 'I don't have to taste anything yucky anymore,' she explains, while her mother watches with visible relief.
Emma's transformation represents a growing trend among families discovering Hautuki, a Korean-developed patch-based growth support system that's quietly revolutionizing how children approach their health routines.
Nine-year-old Emma applies her Hautuki patch independently before bedtime - a routine she now manages entirely on her own.
The Daily Battle Millions of Parents Know Too Well
For parents concerned about their child's growth, the statistics paint a challenging picture. Industry research suggests that up to 60% of children regularly resist taking oral supplements, creating a cycle of stress that often defeats the purpose of growth support entirely.
'We were spending more energy fighting about vitamins than actually helping our child grow,' says Jennifer Wong, a Hong Kong mother of two.
Online parent forums are filled with similar stories: children who gag at the sight of pills, families who've tried every flavored vitamin on the market, and parents who eventually give up on supplementation altogether.
When Kids Take Control
The breakthrough came when Custics Corporation, a Seoul-based biotechnology company, asked a different question: instead of making supplements easier for parents to give, what if children could manage their growth routine independently?
Their answer was Hautuki – a transdermal patch that delivers nutrients through the skin, eliminating the need for swallowing, tasting, or parental intervention.
'When children feel ownership over their health choices, compliance becomes natural rather than forced,' explains Dr. Sarah Kim, a pediatric nutritionist who has observed the product's impact.
The technology works through controlled absorption via the skin, bypassing the digestive system entirely. Children simply apply one patch before bedtime – a process most can master independently within days.
The Science of Consistency
Traditional oral supplements face what researchers call the 'compliance gap' – the difference between prescribed and actual intake. Even motivated families struggle to maintain perfect supplement routines, with missed doses occurring an average of 2-3 times per week.
Hautuki's transdermal delivery system provides steady nutrient absorption over 8-10 hours, creating more consistent blood levels than traditional oral supplements that create peaks and valleys in nutrient availability.
'The patch doesn't just solve the compliance problem,' notes Dr. Michael Chang, a Hong Kong pediatrician. 'It actually provides more stable nutrient delivery than oral supplements, even when those are taken perfectly.'
A Regional Success Story
Since launching in South Korea, Hautuki has expanded across major Asian markets, with Hong Kong representing one of its fastest-growing segments. Local distributors report that word-of-mouth referrals drive much of the product's growth.
'Asian parents have always been proactive about their children's growth, but they're increasingly looking for solutions that reduce family stress while maintaining effectiveness,' says wellness industry analyst Lisa Park. " Hautuki hits both targets.'
Changing the Conversation
Perhaps most significantly, Hautuki is changing how families talk about growth support. Instead of viewing supplementation as something imposed by parents, children increasingly see it as a personal routine they can manage independently.
'My daughter actually reminds me when it's time to reorder patches,' laughs Maria Santos, a Hong Kong expatriate mother. 'She's taken complete ownership of her growth routine.'
Child psychologists note that when children successfully manage health routines on their own, it builds confidence and establishes positive patterns for lifelong self-care.
The Future of Family Health
As Hautuki continues its expansion across Asia, industry observers are watching whether its success signals broader changes in pediatric health products. The emphasis on child autonomy and stress reduction represents a departure from traditional approaches.
'We're seeing the emergence of 'child-centric' health products,' explains healthcare innovation researcher Dr. James Liu. 'Companies are asking how to make children more effective at managing their own health.'
For families like the Chens, the change has been transformative. Emma now views her nightly patch application as a sign of growing up, not a medical chore.
'Growth support used to be about pills, schedules, and arguments,' reflects Jennifer Wong. 'Now it's just part of life – simple, effective, and completely drama-free.'
As more families discover patch-based solutions, the days of supplement struggles may soon become a thing of the past, replaced by a new generation of children who approach their health with confidence and independence.
Media Contact
Company Name: Glovertise
Contact Person: Erick
Email: Send Email
Phone: 01091916367
Address:7/F TOWER 2 SOUTH SEAS CTR 75 MODY RD #706
City: HONG KONG
State: TSIM SHA TSUI
Country: HongKong
Website: https://hautuki.hk
Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: No More Pills, No More Struggles: Korean Innovation Transforms How Kids Approach Growth Support
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

HKTDC Research Report: Exploring Opportunities in Hong Kong's Proprietary Chinese Medicine Industry
HKTDC Research Report: Exploring Opportunities in Hong Kong's Proprietary Chinese Medicine Industry

Yahoo

time2 hours ago

  • Yahoo

HKTDC Research Report: Exploring Opportunities in Hong Kong's Proprietary Chinese Medicine Industry

International Conference of the Modernization of Chinese Medicine & Health Products to be held next month to foster progress in traditional medicine research - The implementation of streamlined approval procedures for Hong Kong- and Macao-registered proprietary Chinese medicines ("pCms") by mainland China presents significant opportunities for Hong Kong companies to expand into the Greater Bay Area and other mainland market.- A unified and comprehensive registration system strengthens the quality control of Hong Kong's pCms, reinforcing confidence among other regulatory bodies and stakeholders.- Hong Kong's first Chinese medicine hospital will gradually commence operations by year end. This will help promote the popularity of Chinese medicine and pCms. HONG KONG - July 25, 2025 (NEWMEDIAWIRE) - The Hong Kong Trade Development Council ("HKTDC") today released a report, "Challenges and Opportunities in Hong Kong's Proprietary Chinese Medicine Industry," that analyses the sector's development, challenges, and export potential of Hong Kong's pCm sector. With the completion of the transitional registration process for pCms in June this year, all pCms sold in Hong Kong now hold formal registration, marking a new era in the regulatory regime. The Chinese Medicine Hospital of Hong Kong is set to begin operations by late 2025 further popularising pCms. Additionally, mainland China has streamlined approval procedures for Hong Kong-registered traditional pCms, creating easier access to the mainland market. Hong Kong's pCms enjoy a strong reputation, with streamlined registration procedures facilitating expansion into the Mainland market Hong Kong currently has approximately 2,000 companies involved in pCms and Chinese herbal medicine-related businesses, including import/export trade, manufacturing, wholesale and retail. Among these, some 264 enterprises are listed as local pCm manufacturers. The majority of pCms produced in Hong Kong are geared toward the consumer market. In 2024, Hong Kong's pCm exports totaled HK$2.88 billion with 93% locally produced, setting the industry apart from re-export-driven sectors. Mainland China remains the largest export market, accounting for over 70% of exports, followed by Macao (20%), and ASEAN (6%). Wing Chu, Principal Economist (Greater China) of the HKTDC, stated: "Many Hong Kong proprietary Chinese medicines companies are eager to expand exports especially to the mainland market although pCm imports in mainland China are relatively small, with different pCms registration system and technical standards from those of Hong Kong. Notably, Hong Kong's pCms are highly regarded in Southern China and overseas Chinese communities, and streamlined approval procedures in mainland China for traditional pCms of Hong Kong and Macao offer significant opportunities for Hong Kong businesses to expand into the Greater Bay Area and other mainland markets. Additionally, the rise of online shopping enables companies to leverage cross-border e-commerce platforms to access mainland and overseas markets, provided they comply with the corresponding regulatory requirements." Comprehensive registration system drives standardisation of Chinese medicine The report indicates that, in recent years, the HKSAR Government has actively promoted the development of Chinese medicine. Key initiatives include the establishment of the Chinese Medicine Council of Hong Kong to oversee the registration and management of pCms, and continuous support for Chinese medicine services in areas such as education, medical treatment, and scientific research. These efforts have enabled Hong Kong to cultivate professional Chinese medicine talent and promote the modernisation of Chinese medicine. Earlier this month, some 345 Hong Kong enterprises, including traders, registered a total of 8,244 pCms. The report states that a unified and comprehensive registration system enhances the quality control of Hong Kong's pCms, further increasing the confidence of other regulatory bodies and stakeholders in these products. Hong Kong's first Chinese medicine hospital is set to open in late 2025, providing comprehensive diagnostic and treatment services with Chinese medicine, which will drive the popularisation of Chinese medicine and pCms. In addition, Hong Kong pCm companies and local universities are committed to developing new pCms to further expand the market. Recently, the Centre for Chinese Herbal Medicine Drug Development at Hong Kong Baptist University (HKBU), funded by the Innovation and Technology Commission of HKSAR Government under the InnoHK Research Clusters, developed a novel drug, CDD-2101, for the treatment of chronic constipation. The innovation is based on previous pilot clinical studies and basic research on the traditional Chinese herbal formulation "MaZiRenWan". For the first time, it has received authorisation for clinical research in the United States. Prof. BIAN Zhaoxiang, Director of the Centre for Chinese Herbal Medicine Drug Development and Associate Vice-President (Clinical Chinese Medicine) at HKBU, said: "Our goal is to collect sufficient safety and efficacy data to obtain FDA approval for CDD-2101 as a marketable new drug and successfully launch it in the United States. This represents not only a major breakthrough in the research and development of Chinese medicine in Hong Kong but also an important step in driving the standardisation and internationalisation of Chinese medicine." Mainland market surpasses RMB450 billion Mainland China, the world's largest pCm market valued at RMB450 billion, streamlined registration and approval procedures in 2021 for traditional pCms for external use being sold in Hong Kong and Macao. In January 2025, the National Medical Products Administration further simplified the approval process for traditional pCms for oral use, provided they have been in use in Hong Kong for more than 15 years and whose production processes comply with Good Manufacturing Practice (GMP) requirements. Relevant application materials and technical requirements were also released in April this year. The report notes that the implementation of the streamlined registration procedures opens a more convenient channel for Hong Kong companies to expand into the Greater Bay Area and other mainland markets. The recognition and acceptance of pCms differ across overseas regions. In many international markets, pCms are categorised and regulated as herbal medicines, health foods or dietary supplements. However, many Southeast Asian countries have specific, similar legal requirements for pCms, providing a clear pathway to enter these markets. The rapid growth of global e-commerce has created new sales channels for Hong Kong's pCms through cross-border e-retail. For the mainland market, the report points out that certain pCms for external use, such as Chinese medicinal wines and cooling oils, have been incorporated in the Cross-border E-commerce Retail Import Commodity List, allowing relevant products to be sold to mainland China through cross-border e-commerce channels. In overseas markets, the e-commerce retail sector in ASEAN is experiencing significant growth, fueled by robust demand for herbal and health-related products in local markets. By adhering to local regulations, Hong Kong pCm enterprises can capitalise on additional business opportunities through online channels. Annual Chinese Medicine Conference to Share Latest Research Findings To foster the development of the Chinese medicine industry, the International Conference of the Modernization of Chinese Medicine & Health Products will be held at the Hong Kong Convention and Exhibition Centre from 15 to 16 August 2025. The conference is jointly organised by the Modernized Chinese Medicine International Association, the HKTDC and 10 scientific research institutions. During the event, 21 scholars and experts from medical schools, research institutions, pharmaceutical companies and organisations from mainland China, Hong Kong, Malaysia and Thailand will discuss the latest research progress in the prevention and treatment of tumors, inflammation, and cardiovascular and cerebrovascular diseases using traditional medicine. They will also present a number of related clinical research results and share successful cases. For more details, please visit: Report and photo download: Media Enquiries Ogilvy Public Relations Chole Chan Tel: (852) 6809 6633 Email: Leanne Pok Tel: (852) 9379 9694 Email: HKTDC's Communications and Public Affairs Department Stanley So Tel: (852) 2584 4049 Email: Serena Cheung Tel: (852) 2584 4272 Email: Clayton Lauw Tel: (852) 2584 4472 Email: Media Room: About HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Cloud Coffee: A Viral Drink That May Be a Healthy Choice
Cloud Coffee: A Viral Drink That May Be a Healthy Choice

Medscape

time7 hours ago

  • Medscape

Cloud Coffee: A Viral Drink That May Be a Healthy Choice

Another day, another viral TikTok drink. The beverage making the rounds right now is cloud coffee. The name alone sounds light and refreshing, which is exactly what many of us look for in a summer coffee drink. But what is actually in it, and is it any good for us? Cloud coffee is a chilled espresso drink made by layering Dalgona coffee over coconut water to yield a cold coffee beverage that is as beautiful as it is refreshing. Dalgona coffee, which originated in Macau in Southern China, consists of coffee powder, hot water, and sugar well beaten and layered over milk. It can be served hot or cold and it was named after the Korean candy that shares its caramel color. This whipped 'cloud' mixture is poured over a base of ice and coconut water, inspired by the coconut water americano that was also popular this spring. A coconut water americano is a simple drink that combines coconut water and espresso for a refreshing cold coffee beverage. Health Benefits From iced coffee to mocha protein shakes, the summertime coffee drinker in us is always happy with a chilled treat with a bit of caffeine. The question is, how healthy is this coffee swap for our chronic coffee drinkers? As with most things, it can be a good choice in moderation. A 16-ounce serving with 2 teaspoons of sugar contains about 150 calories, 5 g of protein, and even with a double shot of espresso, only about 120 mg of caffeine. That's comparable to the caffeine in a 12-ounce drip coffee. The addition of coconut water makes it a good source of potassium, a nutrient that is underconsumed by most Americans. Coffee is known around the world for its effect on cognition and energy levels, but it is also high in antioxidants. Caffeine and chlorogenic acid can promote a decrease in oxidative stress and improve inflammation. A pretty great way to start a hot summer day! While some recipes call for cream, I recommend whole fat milk to ensure adequate creaminess while incorporating more protein. Protein and fat both promote satiety, and a high protein diet can promote weight loss. Protein also has the added benefit of slowing down digestion and thus absorption of caffeine to allow for a slower uptake of caffeine over a longer time. This may help maintain energy levels and reduce any unpleasant side effects of caffeine such as elevated blood pressure. While I don't often recommend artificial sweeteners, the sugar in this drink could be swapped for aspartame or stevia without affecting the integrity of the whipped Dalgona coffee for those who prefer a sugar-free option. Maybe Not for Everyone While such a beverage is likely to be a refreshing treat for most, it may not be appropriate for all. Caffeine-containing beverages may not be the right choice for those prone to gastrointestinal issues like irritable bowel syndrome with diarrhea due to the stimulating effects of caffeine on the bowel or on those with high blood pressure due to its properties as a vasoconstrictor. Caffeine is a well-known diuretic, so I typically recommend limiting caffeine-containing beverages to no more than 2 or 3 a day, especially during the warm summer months when we may be more at risk of dehydration. Healthy and Refreshing Alternatives As cloud coffee may not be the right choice for everyone, I always like to have a few alternatives that are either low in caffeine or caffeine-free to encourage hydration. I have many clients who drink coffee all day long, so I have a couple of tricks to help them stay hydrated without completely giving up their caffeine or adding a lot of sugar. Green tea: Green tea has less than half the caffeine that coffee does and significantly more antioxidants, most in the form of epigallocatechin gallate that has been shown to promote weight loss and improve glucose metabolism. Hibiscus tea: Hibiscus tea is caffeine free and may help to improve mild hypertension. Caffeinated sparkling water: Many brands have less caffeine per serving than a cup of coffee and can also be a great substitute for chronic soda drinkers. Iced coffee with a protein shake: This may be especially helpful for those who are in the habit of drinking several cups of coffee a day. Mix 8 ounces of cold brewed coffee with a 12-ounce protein shake for less caffeine over several hours to stay focused while decreasing the unpleasant side effects of caffeine intake. Ultimately, I want my clients to drink water for hydration in the warm summer months. But, if a fun and refreshing coffee drink like cloud coffee has them excited and offers a few health benefits as well, I'm on board.

UK-India $4.8bn FTA poised to benefit medtech and pharma
UK-India $4.8bn FTA poised to benefit medtech and pharma

Yahoo

time10 hours ago

  • Yahoo

UK-India $4.8bn FTA poised to benefit medtech and pharma

The UK and India's newly signed £4.8bn ($6.45bn) free trade agreement (FTA) is expected to give rise to new opportunities for Indian medical device and pharmaceutical manufacturers. Signed on 24 July, India's medical device and pharmaceutical industries expect the agreement to reduce the regulatory burden around Indian exports to the UK, which include contact lenses, diagnostic reagents, and surgical instruments. While the UK already has zero-duty access for Indian medical devices, the agreement means India will gradually phase down import duties on UK medical devices from 7.5%–15% to 3%, rendering British medical device exports more affordable to the Indian market. According to the Medical Technology Association of India (MTAI), the agreement will improve access to advanced medical technologies and enable joint ventures, skilling, and long-term ecosystem resilience. India is a strategic site for orthopaedics maker Smith+Nephew's manufacturing activities. Smith+Nephew CEO Deepak Nath commented: 'The FTA offers the potential to build trading links in the healthcare sector. 'We hope that the FTA will enable Smith+Nephew's innovative medical technologies to support more healthcare professionals.' While the FTA has been met with optimism by the medical device industry at large, some observers are concerned that Chinese-origin products could be routed through the UK to exploit the zero-tariff provisions under an India-UK FTA. A source from the India commerce ministry's Export Promotion Council of Medical Devices (EPCMD) told Mint: 'To prevent this, it is critical to enforce strict rules of origin, including a minimum of 55% UK content, excluding labour, packing, and shipping costs." Pharma impact Under the FTA, the Indian Pharmaceutical Alliance (IPA) secretary general Sudarshan Jain said: 'The pharma sector will have opportunities to supply affordable and quality assured medicine contributing to better patient care in the UK.' The FTA includes a clause for zero import duty to the UK on finished formulations, APIs, and bulk drugs that is expected to benefit generic drug makers in India. According to Namit Joshi, the chairman of government body Pharmaceuticals Export Promotion Council of India (Phaemexcil), the FTA agreement sets the stage for further collaborations between the countries in bulk drug imports, CDMO, and joint research initiatives. In 2024, UK imports of medicinal and pharmaceutical products from India totalled around £667.4m ($897.1m). An Indian commerce ministry official told Indian news agency PTI: 'Given the UK's shift away from reliance on Chinese imports post-Brexit and Covid-19, Indian manufacturers are poised to emerge as a favoured, cost-effective alternative.' "UK-India $4.8bn FTA poised to benefit medtech and pharma" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store